We are live on !
Find out more
Anchor Capital Advisors Portfolio holdings
AUM
$3.56B
Turnover
14.23%
1-Year Est. Return
21.74%
This Fund
S&P 500
This Quarter Est. Return
+9.19%
1 Year Est. Return
+21.74%
3 Year Est. Return
+64.34%
5 Year Est. Return
+84.46%
10 Year Est. Return
+291.4%
AUM
$3.56B
AUM Growth
+$46.1M
(+1.3%)
Cap. Flow
-$147M
Cap. Flow % of AUM
Cap. Flow %
-4.14%
Top 10 Holdings %
Top 10 Hldgs %
20.45%
Holding
267
New
16
Increased
42
Reduced
156
Closed
22
Avg Time Held
5.7
years
Top 10 Avg Time Held
2
years
Top 20 Avg Time Held
2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Franco-Nevada
FNV
|
+$35.8M |
| 2 |
American Healthcare REIT
AHR
|
+$34.2M |
| 3 |
Cheniere Energy
LNG
|
+$33.8M |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$31M |
| 5 |
Solstice Advanced Materials
SOLS
|
+$29.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Otis Worldwide
OTIS
|
+$42.8M |
| 2 |
Rexford Industrial Realty
REXR
|
+$35.1M |
| 3 |
Fluor
FLR
|
+$26.3M |
| 4 |
Broadridge
BR
|
+$23M |
| 5 |
Paycom
PAYC
|
+$22.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.23% |
| 2 | Industrials | 15.51% |
| 3 | Technology | 12.98% |
| 4 | Materials | 10.85% |
| 5 | Healthcare | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Union Pacific
UNP
$172B
| $16.2M | 0.45% |
59,443
-3,508
| -6% | -$921K |
2023 Q2
12 quarters
|
|
77
SPDR Gold Trust
GLD
$141B
| $15.7M | 0.44% |
42,601
+41,678
| +4,515% | +$17.3M |
2025 Q4
2 quarters
|
|
78
AbbVie
ABBV
$504B
| $15.3M | 0.43% |
60,716
-1,833
| -3% | -$394K |
2013 Q2
52 quarters
|
|
79
Lockheed Martin
LMT
$127B
| $14.9M | 0.42% |
29,209
-1,103
| -4% | -$596K |
2013 Q2
52 quarters
|
|
80
Parker-Hannifin
PH
$121B
| $14.7M | 0.41% |
15,060
-1,488
| -9% | -$1.36M |
2022 Q1
17 quarters
|
|
81
CME Group
CME
$106B
| $14.6M | 0.41% |
66,072
-999
| -1% | -$276K |
2023 Q1
13 quarters
|
|
82
Realty Income
O
$53.1B
| $12.5M | 0.35% |
201,410
-12,361
| -6% | -$771K |
2025 Q1
5 quarters
|
|
83
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.9B
| $11.7M | 0.33% |
220,463
-621
| -0.3% | -$33K |
2023 Q1
13 quarters
|
|
84
American Tower
AMT
$86.3B
| $11.6M | 0.33% |
70,867
-24,443
| -26% | -$4.4M |
2022 Q1
17 quarters
|
|
85
SLB Ltd
SLB
$73.5B
| $11.2M | 0.32% |
241,955
-23,355
| -9% | -$1.25M |
2024 Q4
6 quarters
|
|
86
Procter & Gamble
PG
$370B
| $10.1M | 0.28% |
69,046
-2,874
| -4% | -$418K |
2013 Q2
52 quarters
|
|
87
AstraZeneca
AZN
$257B
| $9.45M | 0.27% |
49,828
-4,935
| -9% | -$928K |
2023 Q1
13 quarters
|
|
88
TCW Flexible Income ETF
FLXR
$3.63B
| $9.22M | 0.26% |
235,153
+106,609
| +83% | +$4.18M |
2026 Q1
1 quarter
|
|
89
iShares 0-1 Year Treasury Bond ETF
SHV
$23.6B
| $9.05M | 0.25% |
82,035
-52,756
| -39% | -$5.82M |
2022 Q2
16 quarters
|
|
90
Abbott
ABT
$181B
| $9.04M | 0.25% |
99,667
-37,085
| -27% | -$3.38M |
2013 Q2
52 quarters
|
|
91
Apple
AAPL
$5.01T
| $8.09M | 0.23% |
27,959
-936
| -3% | -$268K |
2013 Q3
51 quarters
|
|
92
Thermo Fisher Scientific
TMO
$255B
| $7.85M | 0.22% |
15,660
-308
| -2% | -$148K |
2020 Q3
23 quarters
|
|
93
Boston Scientific
BSX
$64.3B
| $7.68M | 0.22% |
180,002
-283,694
| -61% | -$15.4M |
2013 Q2
52 quarters
|
|
94
JPMorgan Limited Duration Bond ETF
JPLD
$4.06B
| $7.36M | 0.21% |
141,013
+3,894
| +3% | +$203K |
2026 Q1
1 quarter
|
|
95
Schwab US Large-Cap Growth ETF
SCHG
$62.8B
| $7M | 0.2% |
206,771
+6,759
| +3% | +$224K |
2026 Q1
1 quarter
|
|
96
iShares Russell 1000 ETF
IWB
$48.7B
| $5.93M | 0.17% |
14,490
+4
| +0% | +$1.58K |
2016 Q1
41 quarters
|
|
97
Vanguard Short-Term Corporate Bond ETF
VCSH
$44B
| $5.16M | 0.15% |
65,299
-4,145
| -6% | -$328K |
2017 Q1
37 quarters
|
|
98
Progressive
PGR
$127B
| $5.14M | 0.14% |
23,550
-667
| -3% | -$134K |
2020 Q1
25 quarters
|
|
99
Qualcomm
QCOM
$184B
| $4.71M | 0.13% |
25,502
+19,125
| +300% | +$3.58M |
2013 Q2
52 quarters
|
|
100
iShares Russell 1000 Value ETF
IWD
$83.6B
| $4.64M | 0.13% |
19,154
+3,542
| +23% | +$825K |
2014 Q4
46 quarters
|
|
Similar funds
Anchor Capital Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Anchor Capital Advisors held 267 positions worth $3.56B, up 1.3% from $3.51B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Anchor Capital Advisors withdrew a net $147M in Q2 2026, closing 22 positions and reducing 156 holdings. Its most notable exit was Otis Worldwide, an estimated $42.8M position sold in full.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Industrials and Technology.
Against the trend, Anchor Capital Advisors opened a new position in Franco-Nevada worth $32M.
- Anchor Capital Advisors's largest Q2 2026 buy was Franco-Nevada: 153,496 shares worth $32M.
- Anchor Capital Advisors added most to American Healthcare REIT in Q2 2026, an estimated $34.2M increase.
- Anchor Capital Advisors's biggest Q2 2026 reduction was Fluor, cutting an estimated $26.3M.
- Anchor Capital Advisors fully exited Otis Worldwide in Q2 2026, selling an estimated $42.8M.
- Anchor Capital Advisors's ten largest holdings make up 20% of its $3.56B portfolio in Q2 2026.
- Anchor Capital Advisors opened 16 new positions and closed 22 in Q2 2026.
- Anchor Capital Advisors's portfolio value rose 1.3% quarter-over-quarter to $3.56B.
Based on Anchor Capital Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.